Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 5, No. 1, 2011
Issue release date: January – April
Section title: Published: April 2011

Open Access Gateway

Case Rep Gastroenterol 2011;5:192–195

Rapid Development of Intestinal Type Gastric Adenocarcinoma

Oh Y.S. · Massey B.T.
Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisc., USA
email Corresponding Author

Young S. Oh, MD

Division of Gastroenterology and Hepatology, Medical College of Wisconsin

9200 W Wisconsin Ave, Milwaukee, WI 53226 (USA)

Tel. +1 414 955 6831, E-Mail yoh@mcw.edu

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Intestinal type gastric adenocarcinoma is felt to develop over a protracted time period through a series of defined steps. Several potential risk factors for the development of gastric cancer have been identified, including a family history of gastric cancer and Helicobacter pylori infection. We present the case of a patient with neither risk factor who progressed in a 14 month time frame from histologically normal gastric mucosa to early stage intestinal type gastric adenocarcinoma in the setting of diffuse gastric intestinal metaplasia and atrophic gastritis. This patient’s presentation conflicts with our current understanding of the development of intestinal type gastric adenocarcinoma.

© 2011 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Published: April 2011

Published online: April 13, 2011
Issue release date: January – April

Number of Print Pages: 4
Number of Figures: 2
Number of Tables: 0

ISSN: (Print)
eISSN: 1662-0631 (Online)

For additional information: http://www.karger.com/CRG

Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.